Rate My Professor Nicki Packer

Professor Nicki Packer is a Distinguished Professor of Glycoproteomics in the School of Natural Sciences at Macquarie University, serving as Deputy Director of the Macquarie University Biomolecular Discovery Research Centre and Academic Lead of the Australian Proteome Analysis Facility (APAF). She obtained her PhD in Biochemistry from the University of Sydney in 1978. Throughout her extensive career in biochemical research across chemistry and biological sciences, Packer played a key role in establishing APAF in 2002 and co-founding Proteome Systems Limited, where her group developed glycoanalytical technologies and informatics tools. She was appointed Professor at Macquarie University in 2007 and elevated to Distinguished Professor in 2017. Additionally, she held the position of Principal Research Leader at the Institute for Glycomics, Griffith University, from 2017 to 2021.

Packer's research focuses on the structure, function, informatics, and applications of glycans and glycoconjugates as biomarkers, particularly in cancer, therapeutics, microbial infections, immune responses, lung diseases, brain function, fertilisation, and cardiovascular disease. She integrates glycomics with proteomics and bioinformatics, earning international acclaim. Notable awards include the 2025 President's Innovator Award from the Society for Glycobiology, 2022 Simpson Lecturer Award from the Australasian Proteomics Society, 2021 Distinguished Achievement in Proteomic Sciences Award from the Human Proteome Organisation (HUPO), 2015 Molecular and Cellular Proteomics/ASBMB Lectureship Award, 2015 Macquarie University Research Excellence Award, and Fellowship of the Royal Society of Chemistry (FRSC). She co-founded the Human Glycoproteomics Initiative (HGI) within HUPO in 2017 and the Australian Glycoscience Society (Glyco@Oz) in 2019. Packer has authored over 260 peer-reviewed publications, including recent works such as "Dysregulation of glycosaminoglycans during oocyte maturation in vitro: implications for developmental potential" (2026, Glycobiology), "The 2025 Report on the Human Proteome from the HUPO Human Proteome Project" (2026, Journal of Proteome Research), and "Update and new implementation of the MIRAGE reporting guidelines for mass spectrometry experiments in glycoscience" (2026, Molecular & Cellular Proteomics). Her contributions extend to leadership in multiple ARC Centres of Excellence, advancing synthetic biology, nanophotonics, and bioactives.